As of August 2017, women account for 49.6% of the total world population, yet the concern regarding women’s health stands neglected, as a large number of women still do not receive proper healthcare. According to the World Health Organization (WHO), around a thousand women die every day of the consequences of pregnancy and child birth, and one-third of all the female deaths are due to cardiovascular disease and stroke, which are supposed to be predominantly a “male” problem. The top issues regarding healthcare at present are cancer, reproductive health, maternal health, HIV, and sexually transmitted infections, among others.
Currently, reproductive and urinary system related issues are the major ailments affecting women’s health across the globe. Worldwide, women live an average four years longer than men, and with the rising aging population, the population of menopausal women is expected to rise in the future. An estimated 30% of all the post-menopausal women in the U.S. and Europe are affected by osteoporosis, and women are more prone to urinary tract infections (UTI) as compared to men. However, the largest market in the women’s healthcare sector is registered by contraception, which is a major contributor in preventing a considerable number of female deaths worldwide. Sexual and reproductive health problems are responsible for one-third of health issues for women between the ages of 15 and 44 years, and contraception helps in fighting a large number of these issues.
The global women’s health market has been on a rise since the last few years as the critical health awareness is spreading gradually among several parts of the world. The global women’s health market was valued at $30,881.4 million in 2016 and is expected to rise moderately by 2023. The market is predominantly segregated into three types, based on application, namely, post-menopausal health, contraception and urinary tract infections (UTI). Contraceptive accounts for the major share of the market and is expected to maintain the hegemony over the market in the coming years, owing to the rising awareness of birth control methods.
In 2016, conventional contraceptives contributed the major share of the market revenue, whereas emergency contraceptives stood at a single digit rate. However, the emergency contraceptives are expected to witness a rise in the consumption in the coming years. Conventional contraception consists of hormonal pills, which are non-invasive and easy to use, and hence driving the growth of the conventional contraceptive market.
Geographically, North America contributed the highest share of revenue in the market in 2016 and is expected to grow at a CAGR of 3.5% from 2017 to 2023. This growth is attributed to the rising population of elderly women which in turn is leading to increased prevalence of menopausal disorders, as well as the rise in the use of contraceptives among women of reproductive age. The fastest growing region during 2017 and 2023 is expected to be Latin America. The rising geriatric population among women leading to higher incidence of menopause and related diseases is the major factor driving the market.
BIS Healthcare has conducted an extensive market research on ‘Global Women’s Health Market, Analysis and Forecast (2016-2023)‘. The market intelligence report aims at providing an in-depth analysis of the key developmental strategies, marketing strategies and market trend dynamics which include drivers, restraints, and opportunities prevailing in the industry.
For further queries, please write to us at [email protected] or call us at: +1 650 228 0182.